Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
boston top stories
clinical trials
martin shkreli
astrazeneca
biogen
bristol-myers squibb
cancer
celgene
crispr
eli lilly
What
bio
4
×
roundup
4
×
acquisitions
announced
august
biopharma
biotech
black
busy
car
celgene
ceo
collabs
colleagues
companies
continue
covid
daniel
days
deal
debut
decisions
devices
diamond
diamond’s
drugs
exome
fda
gilead
gilead’s
government
health
help
hundreds
indication
industry
introduce
ipo
leading
legacy
Language
unset
Current search:
bio
×
ipo
×
roundup
×
abbvie
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More